ResMed (MEX:RMD) Float Percentage Of Total Shares Outstanding: 86.79% (As of Jul. 01, 2026)


MEX:RMD ResMed Inc MEX:RMD
99 GF Score
Price MXN3,419.00
GF Value MXN4,784.46
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is ResMed Float Percentage Of Total Shares Outstanding?

ResMed MEX:RMD -7.99% 99 Float Percentage Of Total Shares Outstanding is 86.79% as of Jul. 01, 2026. GuruFocus rates MEX:RMD with a GF Score™ of 99/100 and a GF Value™ of MXN4,784.46 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ResMed's float shares is 125.90 Mil. ResMed's total shares outstanding is 145.06 Mil. ResMed's float percentage of total shares outstanding is 86.79%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ResMed's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ResMed's Institutional Ownership is 49.11%.

MEX:RMD
99GF Score
ResMed Inc MEX:RMD
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ResMed Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

ResMed's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=125.90/145.06
=86.79%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 86.79% mean?
ResMed (MEX:RMD) has a Float Percentage Of Total Shares Outstanding of 86.79% as of Jul. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on ResMed and its competitors.
Is ResMed's Float Percentage Of Total Shares Outstanding too high?
ResMed's current Float Percentage Of Total Shares Outstanding is 86.79%. Overall, ResMed has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ResMed's Float Percentage Of Total Shares Outstanding compare to MDLN and WST?
ResMed's Float Percentage Of Total Shares Outstanding of 86.79% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on ResMed and its competitors. ResMed's current Float Percentage Of Total Shares Outstanding is 86.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ResMed stock overvalued right now?
Based on GuruFocus' analysis, ResMed (MEX:RMD) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN4,784.46, compared to a current price of MXN3,419.00 — trading 28.5% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 86.79%. ResMed's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For ResMed (MEX:RMD), the current Float Percentage Of Total Shares Outstanding is 86.79% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ResMed (MEX:RMD) Overvalued in 2026?

Based on GuruFocus' analysis, ResMed stock appears to be undervalued. The current stock price of MXN3,419.00 is trading 28.5% below its estimated GF Value™ of MXN4,784.46. GuruFocus considers ResMed to be Modestly Undervalued.

Key valuation signals for MEX:RMD:

  • Float Percentage Of Total Shares Outstanding: 86.79%
  • GF Value™: MXN4,784.46 vs. price of MXN3,419.00 (28.5% below fair value)
  • GF Score™: 99/100 with 1 warning sign

No single metric tells the full story. See the MEX:RMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ResMed Business Description

Address 9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
99GF Score

Get the complete analysis for MEX:RMD

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,419.00
Price
MXN4,784.46
GF Value